A phase II trial of rosiglitazone in patients with thyroglobulin-positive and radioiodine-negative differentiated thyroid cancer

Surgery ◽

10.1016/j.surg.2006.07.038 ◽

2006 ◽

Vol 140 (6) ◽

pp. 960-967 ◽

Author(s):

Electron Kebebew ◽

Miao Peng ◽

Emily Reiff ◽

Patrick Treseler ◽

Kenneth A. Woeber ◽

...

Keyword(s):

Thyroid Cancer ◽

Phase Ii ◽

Differentiated Thyroid Cancer ◽

Download Full-text

A phase II trial of the multitargeted kinase inhibitor E7080 in advanced radioiodine (RAI)-refractory differentiated thyroid cancer (DTC).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.5503 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 5503-5503 ◽

Author(s):

S. I. Sherman ◽

B. Jarzab ◽

M. E. Cabanillas ◽

L. F. Licitra ◽

F. Pacini ◽

...

Keyword(s):

Thyroid Cancer ◽

Phase Ii ◽

Differentiated Thyroid Cancer ◽

Kinase Inhibitor ◽

Download Full-text

Rexinoid therapy for poorly differentiated thyroid cancer: A pilot clinical phase II trial and correlation to retinoid and peroxisome-proliferator activated receptor gamma receptors expression.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.tps269 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. TPS269-TPS269

Author(s):

L. P. De Oliveira ◽

B. Haugen ◽

M. Kane ◽

A. Jimeno ◽

J. Klopper

Keyword(s):

Thyroid Cancer ◽

Phase Ii ◽

Differentiated Thyroid Cancer ◽

Phase Ii Trial ◽

Peroxisome Proliferator ◽

Peroxisome Proliferator Activated Receptor ◽

Clinical Phase ◽

Poorly Differentiated

Download Full-text

Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial

10.1186/s12885-019-5541-4 ◽

2019 ◽

Vol 19 (1) ◽

Author(s):

Sarah R. Brown ◽

Andrew Hall ◽

Hannah L. Buckley ◽

Louise Flanagan ◽

David Gonzalez de Castro ◽

...

Keyword(s):

Thyroid Cancer ◽

Phase Ii ◽

Clinical Benefit ◽

Differentiated Thyroid Cancer ◽

Radioiodine Therapy ◽

Phase Ii Trial ◽

Potential Clinical Benefit

Download Full-text

1743MO MERAIODE: A redifferentiation phase II trial with trametinib followed by radioactive iodine for metastatic radioactive iodine refractory differentiated thyroid cancer patients with a RAS mutation

Annals of Oncology ◽

10.1016/j.annonc.2021.08.889 ◽

2021 ◽

Vol 32 ◽

pp. S1204

Author(s):

S. Leboulleux ◽

D. Benisvy ◽

D. Taieb ◽

M. Attard ◽

C. Bournaud ◽

...

Keyword(s):

Thyroid Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Differentiated Thyroid Cancer ◽

Radioactive Iodine ◽

Phase Ii Trial ◽

Download Full-text

Donafenib in Progressive Locally Advanced or Metastatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Results of a Randomized, Multicenter Phase II Trial

Thyroid ◽

10.1089/thy.2020.0235 ◽

2020 ◽

Author(s):

Yan-Song Lin ◽

Hui Yang ◽

Yong Ding ◽

Yi-Zhuang Cheng ◽

Feng Shi ◽

...

Keyword(s):

Thyroid Cancer ◽

Phase Ii ◽

Differentiated Thyroid Cancer ◽

Radioactive Iodine ◽

Phase Ii Trial ◽

Locally Advanced ◽

Multicenter Phase

Download Full-text

Surufatinib in Chinese Patients with Locally Advanced or Metastatic Differentiated Thyroid Cancer and Medullary Thyroid Cancer: A Multicenter, Open-Label, Phase II Trial

Thyroid ◽

10.1089/thy.2019.0453 ◽

2020 ◽

Vol 30 (9) ◽

pp. 1245-1253 ◽

Author(s):

Jiaying Chen ◽

Qinghai Ji ◽

Chunmei Bai ◽

Xiangqian Zheng ◽

Yuan Zhang ◽

...

Keyword(s):

Thyroid Cancer ◽

Phase Ii ◽

Differentiated Thyroid Cancer ◽

Medullary Thyroid Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Chinese Patients ◽

Medullary Thyroid ◽

Open Label Phase

Download Full-text

Phase II trial of everolimus with sorafenib for patients with differentiated thyroid cancer (DTC) who progress on sorafenib alone.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.tps263 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. TPS263-TPS263 ◽

Author(s):

M. S. Brose ◽

A. B. Troxel ◽

R. Mamtani

Keyword(s):

Thyroid Cancer ◽

Phase Ii ◽

Differentiated Thyroid Cancer ◽

Download Full-text

A Phase II Trial of Bexarotene for Advanced Differentiated Thyroid Cancer

Thyroid ◽

10.1089/thy.2014.0399 ◽

2015 ◽

Vol 25 (5) ◽

pp. 563-564 ◽

Author(s):

Joshua Klopper ◽

Madeleine Kane ◽

Antonio Jimeno ◽

Sharon Sams ◽

Jena French ◽

...

Keyword(s):

Thyroid Cancer ◽

Phase Ii ◽

Differentiated Thyroid Cancer ◽

Download Full-text

Axitinib Shrinks Thyroid Cancer in Phase II Trial

Internal Medicine News ◽

10.1016/s1097-8690(07)70861-2 ◽

2007 ◽

Vol 40 (14) ◽

pp. 22

Author(s):

JANE SALODOF MACNEIL

Keyword(s):

Thyroid Cancer ◽

Phase Ii ◽

Download Full-text

Faculty Opinions recommendation of Phase II trial of sorafenib in advanced thyroid cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1152897.612953 ◽

2009 ◽

Author(s):

Jerome Hershman ◽

Llanyee Liwanpo

Keyword(s):

Thyroid Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Thyroid Cancer

Download Full-text